{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:50:04Z","timestamp":1770814204720,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10330022010009"],"award-info":[{"award-number":["10330022010009"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"an institutional grant of the Dutch Cancer Society and  of the Dutch Ministry of Health, Welfare and Sport"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10549-026-07898-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:48:39Z","timestamp":1769586519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy"],"prefix":"10.1007","volume":"215","author":[{"given":"Eline M. J.","family":"Lammers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Beens- van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Nijdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schaapveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge M.","family":"Krul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge-Marie","family":"Obdeijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"So-Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe M. P.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"22","key":"7898_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","volume":"30","author":"AJ Swerdlow","year":"2012","unstructured":"Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D et al (2012) Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin\u2019s lymphoma in England and Wales: a national cohort study. J Clin Oncol 30(22):2745\u20132752. https:\/\/doi.org\/10.1200\/JCO.2011.38.8835","journal-title":"J Clin Oncol"},{"issue":"26","key":"7898_CR2","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","volume":"27","author":"ML De Bruin","year":"2009","unstructured":"De Bruin ML, Sparidans J, van\u2019t Veer MB, Noordijk EM, Louwman MW, Zijlstra JM et al (2009) Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27(26):4239\u20134246. https:\/\/doi.org\/10.1200\/JCO.2008.19.9174","journal-title":"J Clin Oncol"},{"issue":"26","key":"7898_CR3","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW et al (2015) Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma. N Engl J Med 373(26):2499\u20132511. https:\/\/doi.org\/10.1056\/NEJMoa1505949","journal-title":"N Engl J Med"},{"issue":"4","key":"7898_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","volume":"99","author":"IM Krul","year":"2017","unstructured":"Krul IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, van Eggermond AM, De Bruin ML et al (2017) Breast cancer risk after radiation therapy for hodgkin lymphoma: influence of gonadal hormone exposure. Int J Radiat Oncol Biol Phys 99(4):843\u2013853. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7898_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/485071","volume":"2015","author":"M Witkowska","year":"2015","unstructured":"Witkowska M, Majchrzak A, Smolewski P (2015) The role of radiotherapy in Hodgkin\u2019s lymphoma: what has been achieved during the last 50 years? Biomed Res Int 2015:485071. https:\/\/doi.org\/10.1155\/2015\/485071","journal-title":"Biomed Res Int"},{"issue":"1","key":"7898_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bjh.15614","volume":"184","author":"HW Wang","year":"2019","unstructured":"Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019) Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol 184(1):45\u201359. https:\/\/doi.org\/10.1111\/bjh.15614","journal-title":"Br J Haematol"},{"issue":"2","key":"7898_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1200\/jco.1994.12.2.312","volume":"12","author":"FE van Leeuwen","year":"1994","unstructured":"van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH et al (1994) Second cancer risk following Hodgkin\u2019s disease: a 20-year follow-up study. J Clin Oncol 12(2):312\u2013325. https:\/\/doi.org\/10.1200\/jco.1994.12.2.312","journal-title":"J Clin Oncol"},{"issue":"2","key":"7898_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1148\/radiology.184.2.1320281","volume":"184","author":"DD Dershaw","year":"1992","unstructured":"Dershaw DD, Yahalom J, Petrek JA (1992) Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology 184(2):421\u2013423. https:\/\/doi.org\/10.1148\/radiology.184.2.1320281","journal-title":"Radiology"},{"key":"7898_CR9","unstructured":"NABON\/NIV Dutch Breast Cancer Guideline - Screening outside of the population screening programme. 2012. https:\/\/www.nabon.nl\/oude-richtlijnen\/ Accessed 12 Mar 2023."},{"issue":"4","key":"7898_CR10","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1111\/bjh.15936","volume":"186","author":"A Nijdam","year":"2019","unstructured":"Nijdam A, Dekker N, Aleman BMP, van \u2019t Veer MB, Daniels LA, van der Maazen RW et al (2019) Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma. Br J Haematol 186(4):e103\u2013e108. https:\/\/doi.org\/10.1111\/bjh.15936","journal-title":"Br J Haematol"},{"issue":"3","key":"7898_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","volume":"138","author":"PA Carney","year":"2003","unstructured":"Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138(3):168\u2013175. https:\/\/doi.org\/10.7326\/0003-4819-138-3-200302040-00008","journal-title":"Ann Intern Med"},{"issue":"22","key":"7898_CR12","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/nejmoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381(22):2091\u20132102. https:\/\/doi.org\/10.1056\/nejmoa1903986","journal-title":"N Engl J Med"},{"issue":"2","key":"7898_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jmri.26654","volume":"50","author":"RM Mann","year":"2019","unstructured":"Mann RM, Kuhl CK, Moy L (2019) Contrast-enhanced MRI for breast cancer screening. J Magn Reson Imaging 50(2):377\u2013390. https:\/\/doi.org\/10.1002\/jmri.26654","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"7898_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/jnci\/djz079","volume":"112","author":"AM Chiarelli","year":"2020","unstructured":"Chiarelli AM, Blackmore KM, Muradali D, Done SJ, Majpruz V, Weerasinghe A et al (2020) Performance measures of magnetic resonance imaging plus mammography in the high risk Ontario breast screening program. J Natl Cancer Inst 112(2):136\u2013144. https:\/\/doi.org\/10.1093\/jnci\/djz079","journal-title":"J Natl Cancer Inst"},{"key":"7898_CR15","unstructured":"Dutch society for Radiation Therapy and Oncology (NVRO). Guidelines for screening for adverse effects after Hodgkin lymphoma. 2016. https:\/\/richtlijnendatabase.nl\/zoek?query=%22na+hodgkinlymfoom%22. Accessed 3 Jul 2023."},{"issue":"16","key":"7898_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1200\/jco.23.01386","volume":"42","author":"SIM Neppelenbroek","year":"2024","unstructured":"Neppelenbroek SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, Rademakers SE, de Weijer RJ et al (2024) Doxorubicin exposure and breast cancer risk in survivors of adolescent and adult Hodgkin lymphoma. J Clin Oncol 42(16):1903\u20131913. https:\/\/doi.org\/10.1200\/jco.23.01386","journal-title":"J Clin Oncol"},{"key":"7898_CR17","unstructured":"The Comprehensive R Archive Network (CRAN). Package \u2018epiR\u2019. https:\/\/cran.r-project.org\/web\/packages\/epiR\/epiR.pdf. Accessed 18 Jun 2025."},{"key":"7898_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2307\/2331986","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404\u2013413. https:\/\/doi.org\/10.2307\/2331986","journal-title":"Biometrika"},{"key":"7898_CR19","unstructured":"The Comprehensive R Archive Network (CRAN). pROC package. https:\/\/cran.r-project.org\/web\/packages\/pROC\/index.html. Accessed 7 Jul 2025."},{"key":"7898_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"issue":"18","key":"7898_CR21","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1200\/jco.2012.46.5732","volume":"31","author":"AK Ng","year":"2013","unstructured":"Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS et al (2013) Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol 31(18):2282\u20132288. https:\/\/doi.org\/10.1200\/jco.2012.46.5732","journal-title":"J Clin Oncol"},{"issue":"16","key":"7898_CR22","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/cncr.28747","volume":"120","author":"MT Tieu","year":"2014","unstructured":"Tieu MT, Cigsar C, Ahmed S, Ng A, Diller L, Millar BA et al (2014) Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer 120(16):2507\u20132513. https:\/\/doi.org\/10.1002\/cncr.28747","journal-title":"Cancer"},{"issue":"1","key":"7898_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1148\/radiol.10100991","volume":"259","author":"JS Sung","year":"2011","unstructured":"Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259(1):65\u201371. https:\/\/doi.org\/10.1148\/radiol.10100991","journal-title":"Radiology"},{"issue":"19","key":"7898_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/jco.18.01099","volume":"37","author":"MJ Ehrhardt","year":"2019","unstructured":"Ehrhardt MJ, Howell CR, Hale K, Baassiri MJ, Rodriguez C, Wilson CL et al (2019) Subsequent breast cancer in female childhood cancer survivors in the St Jude lifetime cohort study (SJLIFE). J Clin Oncol 37(19):1647\u20131656. https:\/\/doi.org\/10.1200\/jco.18.01099","journal-title":"J Clin Oncol"},{"issue":"10","key":"7898_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/jco.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33(10):1128\u20131135. https:\/\/doi.org\/10.1200\/jco.2014.56.8626","journal-title":"J Clin Oncol"},{"issue":"24","key":"7898_CR26","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1002\/cncr.34464","volume":"128","author":"IM Krul","year":"2022","unstructured":"Krul IM, Boekel NB, Kramer I, Janus CPM, Krol ADG, Nijziel MR et al (2022) Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma. Cancer 128(24):4285\u20134295. https:\/\/doi.org\/10.1002\/cncr.34464","journal-title":"Cancer"},{"issue":"3","key":"7898_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-020-05642-1","volume":"181","author":"IM Obdeijn","year":"2020","unstructured":"Obdeijn IM, Mann RM, Loo CCE, Lobbes M, Voormolen EMC, van Deurzen CHM et al (2020) The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. Breast Cancer Res Treat 181(3):581\u2013588. https:\/\/doi.org\/10.1007\/s10549-020-05642-1","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7898_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-014-2888-8","volume":"144","author":"IM Obdeijn","year":"2014","unstructured":"Obdeijn IM, Winter-Warnars GA, Mann RM, Hooning MJ, Hunink MG, Tilanus-Linthorst MM (2014) Should we screen BRCA1 mutation carriers only with MRI? A multicenter study. Breast Cancer Res Treat 144(3):577\u2013582. https:\/\/doi.org\/10.1007\/s10549-014-2888-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7898_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","volume":"163","author":"J Krammer","year":"2017","unstructured":"Krammer J, Pinker-Domenig K, Robson ME, Gonen M, Bernard-Davila B, Morris EA et al (2017) Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 163(3):565\u2013571. https:\/\/doi.org\/10.1007\/s10549-017-4198-4","journal-title":"Breast Cancer Res Treat"},{"key":"7898_CR30","unstructured":"The Netherlands Cancer Registry. Breast cancer data. https:\/\/iknl.nl\/borstkankercijfers. Accessed 3 Aug 2025."},{"issue":"1","key":"7898_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1158\/2159-8290.cd-24-1201","volume":"15","author":"P Bhattacharjee","year":"2025","unstructured":"Bhattacharjee P, Lips EH, Sawyer EJ, Hwang ES, Thompson AM, Wesseling J, Cancer Grand Challenges PC (2025) Conquering overtreatment of DCIS: lessons from PRECISION. Cancer Discov 15(1):28\u201333. https:\/\/doi.org\/10.1158\/2159-8290.cd-24-1201","journal-title":"Cancer Discov"},{"key":"7898_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2018.07.003","volume":"101","author":"MC van Maaren","year":"2018","unstructured":"van Maaren MC, Lagendijk M, Tilanus-Linthorst MMA, de Munck L, Pijnappel RM, Schmidt MK et al (2018) Breast cancer-related deaths according to grade in ductal carcinoma in situ: a Dutch population-based study on patients diagnosed between 1999 and 2012. Eur J Cancer 101:134\u2013142. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.003","journal-title":"Eur J Cancer"},{"key":"7898_CR33","unstructured":"NABON\/NIV. Guideline DCIS. https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/behandeling_dcis.html. Accessed 22 May 2025."},{"key":"7898_CR34","doi-asserted-by":"publisher","unstructured":"Kanbayashi C, Thompson AM, Hwang ES et al. (2019) The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA). Journal of Clinical Oncology. 37, Number 15_suppl. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603"},{"issue":"1","key":"7898_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-006-9230-z","volume":"100","author":"M Kriege","year":"2006","unstructured":"Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH et al (2006) Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat 100(1):109\u2013119. https:\/\/doi.org\/10.1007\/s10549-006-9230-z","journal-title":"Breast Cancer Res Treat"},{"issue":"8480","key":"7898_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0140-6736(86)90882-2","volume":"1","author":"TJ Anderson","year":"1986","unstructured":"Anderson TJ, Lamb J, Alexander F, Lutz W, Chetty U, Forrest AP et al (1986) Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project. Lancet 1(8480):519\u2013523. https:\/\/doi.org\/10.1016\/s0140-6736(86)90882-2","journal-title":"Lancet"},{"issue":"5","key":"7898_CR37","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2214\/ajr.179.5.1791173","volume":"179","author":"ES Burnside","year":"2002","unstructured":"Burnside ES, Sickles EA, Sohlich RE, Dee KE (2002) Differential value of comparison with previous examinations in diagnostic versus screening mammography. AJR Am J Roentgenol 179(5):1173\u20131177. https:\/\/doi.org\/10.2214\/ajr.179.5.1791173","journal-title":"AJR Am J Roentgenol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07898-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:28:51Z","timestamp":1770802131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7898"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07898-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests related to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Boards of Erasmus Medical Center and The Netherlands Cancer Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Survivors who objected to the use of their medical data for research purposes were not included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"64"}}